Ki-67 index of 5% could better predict the clinical prognosis of well-differentiated pancreatic neuroendocrine tumours.
Bing YuanYanfen ShiYuanliang LiHaidong TanPeipei JiaoWenting SuMeng LiuZhirong QiHuang-Ying TanJie LuoPublished in: Japanese journal of clinical oncology (2021)
Thus, differentiating pNETG1/pNETG2 with Ki-67 index (5%) is proposed as the cut-off value and a new Ki-67 index (5%) is a better predictor of pNET mortality and post-operative recurrence than Ki-67 index (3%).